TRIM66 confers tumorigenicity of hepatocellular carcinoma cells by regulating GSK-3β-dependent Wnt/β-catenin signaling. | |
Fan Wanhu; Du Fenjing; Liu Xiaojing | |
刊名 | European journal of pharmacology
![]() |
2019 | |
卷号 | 850页码:109-117 |
关键词 | &beta -catenin GSK-3&beta hepatocellular carcinoma TRIM66 |
ISSN号 | 1879-0712 |
URL标识 | 查看原文 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/2828874 |
专题 | 西安交通大学 |
推荐引用方式 GB/T 7714 | Fan Wanhu,Du Fenjing,Liu Xiaojing. TRIM66 confers tumorigenicity of hepatocellular carcinoma cells by regulating GSK-3β-dependent Wnt/β-catenin signaling.[J]. European journal of pharmacology,2019,850:109-117. |
APA | Fan Wanhu,Du Fenjing,&Liu Xiaojing.(2019).TRIM66 confers tumorigenicity of hepatocellular carcinoma cells by regulating GSK-3β-dependent Wnt/β-catenin signaling..European journal of pharmacology,850,109-117. |
MLA | Fan Wanhu,et al."TRIM66 confers tumorigenicity of hepatocellular carcinoma cells by regulating GSK-3β-dependent Wnt/β-catenin signaling.".European journal of pharmacology 850(2019):109-117. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论